← back to search

Yao Luo

University of Science and Technology of China · CN
Area of research
Molecular Biology · Health, Toxicology and Mutagenesis
Research interest
Research interests include Advanced biosensing and bioanalysis techniques, Mercury impact and mitigation studies, Nanoplatforms for cancer theranostics, and Geology and Paleoclimatology Research.
h-index
33
citations
3,875
works
215
NIH funding
primary concept
email

Recent publications

Editorial: Environmentally-responsive biomaterials for major diseases treatment
Frontiers in Bioengineering and Biotechnology 2025cited by 1position: lastdoi
pH-Responsive Charge Convertible Hyperbranched Poly(ionic liquid) Nanoassembly with High Biocompatibility for Resistance-Free Antimicrobial Applications
Nano Letters 2024cited by 19position: middledoi
Malignancy risk stratification prediction of BI-RADS 4B calcifications based on contrast-enhanced mammographic features: a multicenter study
Breast Cancer Research and Treatment 2024cited by 1position: middledoi
Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera
Nature Communications 2023cited by 48position: middledoi
Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating <scp>THBS1</scp>
Phytotherapy Research 2023cited by 17position: middledoi
The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment
Frontiers in Immunology 2022cited by 49position: lastdoi
Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota
Phytomedicine 2022cited by 49position: middledoi
Deep Tumor Penetrating Gold Nano‐Adjuvant for NIR‐II‐Triggered In Situ Tumor Vaccination
Small 2022cited by 33position: middledoi
Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma
Journal of Medicinal Chemistry 2021cited by 93position: middledoi
Antitumor Effects of Baicalein and Its Mechanism via TGFβ Pathway in Cervical Cancer HeLa Cells
Evidence-based Complementary and Alternative Medicine 2021cited by 13position: middledoi
Suppressive activities of mangiferin on human epithelial ovarian cancer
Phytomedicine 2020cited by 49position: middledoi
Synergy between Auranofin and Celecoxib against Colon Cancer In Vitro and In Vivo through a Novel Redox-Mediated Mechanism
Cancers 2019cited by 61position: middledoi
In Situ Spatial Complementation of Aptamer‐Mediated Recognition Enables Live‐Cell Imaging of Native RNA Transcripts in Real Time
Angewandte Chemie International Edition 2017cited by 96position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Huidi Liu · South China Agricultural University3 papers (2020–2023)Caiji Lin · Harbin Medical University3 papers (2020–2023)Pengfei Wang · Qingdao University3 papers (2020–2023)Zheng Zeng · University of Kentucky3 papers (2020–2023)Peng Huang · Wildlife Conservation Society3 papers (2019–2023)Shu‐Lin Liu · Xi'an University of Science and Technology3 papers (2020–2023)Jiaming Yang · Tianjin Medical University3 papers (2020–2023)Wenhua Lu · Sun Yat-sen University2 papers (2019–2023)Yumin Hu · Sun Yat-sen University2 papers (2021–2023)Kaihong Xie · Harbin Medical University2 papers (2020–2023)Jun Yue · Zhejiang Chinese Medical University2 papers (2022–2024)Shijun Wen · Tibet University2 papers (2019–2021)Danli Cao · Harbin Medical University2 papers (2022–2023)Panpan Liu · Sun Yat-sen University2 papers (2019–2021)Hao Yang · Jiangnan University1 papers (2022–2022)Donglin Xia · Nantong University1 papers (2025–2025)Mingyue Zhao · Ningbo University1 papers (2023–2023)Wenwen Xu · Anhui Agricultural University1 papers (2020–2020)Bingyan Lin · Sun Yat-sen University1 papers (2024–2024)Shuang Qiao · Sun Yat-sen University1 papers (2021–2021)